Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A kind of coumarin-platinum (ii) complex targeting drug-resistant strains of lung cancer and its synthesis method and application

A synthetic method, technology of coumarin derivatives, applied in the preparation of anti-tumor drugs, coumarin-platinum complex and its synthesis field, can solve the problems of drug resistance, toxic and side effects, etc., and achieve high yield , good selectivity, and easy control of synthetic reaction conditions

Active Publication Date: 2021-08-13
YULIN NORMAL UNIVERSITY
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Nowadays, metal complexes have been widely used in medical fields such as early tumor detection test strips, some clinical drugs or diagnostic reagents, but their toxic side effects and drug resistance urgently require researchers to design a high-efficiency and low-toxicity metal antineoplastic drugs

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of coumarin-platinum (ii) complex targeting drug-resistant strains of lung cancer and its synthesis method and application
  • A kind of coumarin-platinum (ii) complex targeting drug-resistant strains of lung cancer and its synthesis method and application
  • A kind of coumarin-platinum (ii) complex targeting drug-resistant strains of lung cancer and its synthesis method and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0029] Weigh 2.0mol of coumarin derivative H-QC1 and 1.0mol of dichlorobis(dimethylsulfoxide) platinum (II) in a 50.0mL autoclave, add 25.0mL of methanol, and Seal the reaction at ℃ for 24h, and obtain the reddish-brown target complex QC1-Pt. The yield was 93.4%.

Embodiment 2

[0031] Weigh 2.0mol of coumarin derivatives H-QC2 and 1.0mol of dichlorobis(dimethylsulfoxide) platinum (II) in a 50.0mL autoclave, add 35.0mL of ethanol, at 37 The reddish-brown target complex QC2-Pt was obtained after sealing reaction at ℃ for 2 hours. The yield was 80.2%.

Embodiment 3

[0033] Weigh 2.0mol of coumarin derivative H-QC2 and 1.0mol of dichlorobis(dimethylsulfoxide) platinum (II) in a 50.0mL autoclave, add 10.0mL of methanol and acetone ( v:v=13::1), and sealed reaction at 80°C for 12 hours, the reddish-brown target complex QC3-Pt was obtained. The yield was 87.5%.

[0034] The synthesis route of the coumarin-platinum (II) complex targeting human lung cancer drug-resistant strains of the present invention is as follows:

[0035]

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a coumarin-platinum (II) complex targeting drug-resistant strains of lung cancer, its synthesis method and the application of the complex in the preparation of antitumor drugs. The synthesis method of the coumarin-platinum (II) complex targeting lung cancer drug-resistant strains comprises the following steps: (1) combining coumarin derivatives and dichloro-bis(dimethylsulfoxide) platinum (II) Add a polar solvent to obtain a mixed solution; (2) react the obtained mixed solution at 37-80°C to obtain a precipitate; (3) wash and dry the precipitate to obtain a reddish-brown target product. The present invention uses coumarin derivatives as active ligands for the first time, after coordinating with platinum (II), three novel coumarin-platinum (II) complexes QC1-Pt, QC2-Pt and QC3-Pt are generated, showing It has excellent anti-tumor activity and targeting in vitro and in vivo, has potential medicinal value, and is expected to be used in the preparation of various anti-tumor drugs.

Description

technical field [0001] The invention relates to a platinum-based highly active complex and a synthesis method, in particular to a coumarin-platinum (II) complex targeting drug-resistant strains of lung cancer and a synthesis method thereof. The invention also relates to the application of the coumarin-platinum (II) complex targeting drug-resistant strains of lung cancer in the preparation of antitumor drugs. Background technique [0002] As early as 1978, the U.S. Food and Drug Administration approved cisplatin for the treatment of lung cancer, testicular cancer, bone cancer and early ovarian cancer. Cisplatin and other platinum complexes have had a huge impact on the treatment of cancer and are used in most anticancer chemotherapy regimens, creating a precedent for inorganic metal complexes to enter anticancer drugs. Nowadays, metal complexes have been widely used in medical fields such as early tumor detection test strips, some clinical drugs or diagnostic reagents, but t...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07F15/00A61P35/00
CPCA61P35/00C07F15/0086
Inventor 覃其品王振凤黄小玲谭明雄苏雨婕曾嘉静罗细凤罗小玲
Owner YULIN NORMAL UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com